This indicator will be updated in the second half of 2024.
The economic costs of NCDs can be divided into direct and indirect costs.
For Switzerland, the total direct costs of NCDs in 2011 were estimated at just under CHF 52 billion. This means that NCDs accounted for 80% of all direct health care expenditure (not shown in indicator; see Wieser et al. 2014). Social insurance made up the largest share of the direct costs which are caused to a significant extent by cardiovascular diseases, musculoskeletal diseases and mental disorders.
In 2011, the total of direct and indirect costs for the seven main NCDs was approximately CHF 74 billion.
This indicator is part of the Monitoring System Addiction and NCD (MonAM) of the Federal Office of Public Health (FOPH).
Non-communicable diseases (NCDs) are a burden not only on the person who is ill and those around them; they also entail high direct and indirect costs for society. A major objective of the NCD strategy is to curb all costs attributable to non-communicable diseases.
Direct costs are monetary expenditure attributed to medical and non-medical measures. Indirect costs do not involve money but a loss of resources occurs, mostly due to reduced productivity (e.g. absence from work). Intangible costs such as pain or sorrow are not included in this cost estimate.
The indicator shows an estimate for the direct costs of all NCDs, which are further subdivided into the following three financing schemes:
In addition, the total of the direct and indirect costs of the seven most important NCDs is shown: Cardiovascular diseases, musculoskeletal diseases, mental disorders, cancer, chronic respiratory diseases, dementia, diabetes and other NCDs.
Detailed definitions and calculations can be found in the study of Wieser et al. (2014).
Federal Office of Public Health FOPH
Tel. +41 58 462 95 05